|
Volumn 28, Issue 10, 2009, Pages 1023-1030
|
Registry of the International Society for Heart and Lung Transplantation: Twelfth Official Pediatric Lung and Heart/Lung Transplantation Report-2009
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LYMPHOCYTE ANTIBODY;
ARTICLE;
BRONCHIECTASIS;
BRONCHIOLITIS OBLITERANS;
CAUSE OF DEATH;
CHRONIC OBSTRUCTIVE LUNG DISEASE;
CONGENITAL HEART DISEASE;
DIABETES MELLITUS;
EISENMENGER COMPLEX;
EMPHYSEMA;
FOLLOW UP;
GROUPS BY AGE;
HEART TRANSPLANTATION;
HUMAN;
HYPERLIPIDEMIA;
HYPERTENSION;
IMMUNOSUPPRESSIVE TREATMENT;
INTERSTITIAL PNEUMONIA;
KAPLAN MEIER METHOD;
KIDNEY DISEASE;
LOG RANK TEST;
LUNG DYSPLASIA;
LUNG FIBROSIS;
LUNG TRANSPLANTATION;
MEDICAL SOCIETY;
MORBIDITY;
PEDIATRIC SURGERY;
PREVALENCE;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
PULMONARY VASCULAR DISEASE;
REGISTER;
RETRANSPLANTATION;
RISK FACTOR;
SURVIVAL;
ADOLESCENT;
BRONCHIOLITIS OBLITERANS;
CHILD;
CHILD, PRESCHOOL;
EUROPE;
FOLLOW-UP STUDIES;
HEART-LUNG TRANSPLANTATION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INFANT;
INFANT, NEWBORN;
INTERNATIONAL AGENCIES;
KAPLAN-MEIERS ESTIMATE;
LUNG NEOPLASMS;
LUNG TRANSPLANTATION;
NORTH AMERICA;
OUTCOME ASSESSMENT (HEALTH CARE);
REGISTRIES;
RISK FACTORS;
SURVIVAL RATE;
|
EID: 70349240683
PISSN: 10532498
EISSN: None
Source Type: Journal
DOI: 10.1016/j.healun.2009.08.002 Document Type: Article |
Times cited : (39)
|
References (3)
|